JP2017533265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533265A5 JP2017533265A5 JP2017542212A JP2017542212A JP2017533265A5 JP 2017533265 A5 JP2017533265 A5 JP 2017533265A5 JP 2017542212 A JP2017542212 A JP 2017542212A JP 2017542212 A JP2017542212 A JP 2017542212A JP 2017533265 A5 JP2017533265 A5 JP 2017533265A5
- Authority
- JP
- Japan
- Prior art keywords
- range
- concentration
- minoxidil
- alopecia
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000004384 Alopecia Diseases 0.000 claims 22
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims 20
- 229960003632 minoxidil Drugs 0.000 claims 20
- 239000003814 drug Substances 0.000 claims 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 18
- 229960002256 spironolactone Drugs 0.000 claims 11
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 claims 11
- 208000024963 hair loss Diseases 0.000 claims 10
- 230000003676 hair loss Effects 0.000 claims 10
- 239000011780 sodium chloride Substances 0.000 claims 9
- 231100000360 alopecia Toxicity 0.000 claims 8
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 claims 6
- 229960000997 bicalutamide Drugs 0.000 claims 6
- 229960000978 cyproterone acetate Drugs 0.000 claims 5
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims 5
- 229960004199 dutasteride Drugs 0.000 claims 5
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 claims 5
- 229960004671 enzalutamide Drugs 0.000 claims 5
- WXCXUHSOUPDCQV-UHFFFAOYSA-N enzalutamide Chemical compound C1=C(F)C(C(=O)NC)=CC=C1N1C(C)(C)C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C1=S WXCXUHSOUPDCQV-UHFFFAOYSA-N 0.000 claims 5
- 229960004039 finasteride Drugs 0.000 claims 5
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 claims 5
- 229960002074 flutamide Drugs 0.000 claims 5
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 claims 5
- 229960002653 nilutamide Drugs 0.000 claims 5
- XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 claims 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 4
- 230000000284 resting effect Effects 0.000 claims 4
- 239000011701 zinc Substances 0.000 claims 4
- 229910052725 zinc Inorganic materials 0.000 claims 4
- 241000202807 Glycyrrhiza Species 0.000 claims 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 2
- 208000002720 Malnutrition Diseases 0.000 claims 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 2
- 208000024799 Thyroid disease Diseases 0.000 claims 2
- 229940083712 aldosterone antagonist Drugs 0.000 claims 2
- 239000002170 aldosterone antagonist Substances 0.000 claims 2
- 208000004631 alopecia areata Diseases 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 201000002996 androgenic alopecia Diseases 0.000 claims 2
- 208000007502 anemia Diseases 0.000 claims 2
- 230000002280 anti-androgenic effect Effects 0.000 claims 2
- 239000000051 antiandrogen Substances 0.000 claims 2
- 229960001948 caffeine Drugs 0.000 claims 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 2
- 210000004209 hair Anatomy 0.000 claims 2
- 210000003780 hair follicle Anatomy 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 229940010454 licorice Drugs 0.000 claims 2
- 230000001071 malnutrition Effects 0.000 claims 2
- 235000000824 malnutrition Nutrition 0.000 claims 2
- 239000003956 nonsteroidal anti androgen Substances 0.000 claims 2
- 208000015380 nutritional deficiency disease Diseases 0.000 claims 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 2
- 239000011669 selenium Substances 0.000 claims 2
- 229910052711 selenium Inorganic materials 0.000 claims 2
- 230000003637 steroidlike Effects 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- 208000003024 Diffuse alopecia Diseases 0.000 claims 1
- 206010068168 androgenetic alopecia Diseases 0.000 claims 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014904327 | 2014-10-29 | ||
| AU2014904327A AU2014904327A0 (en) | 2014-10-29 | Detection and treatment of excessive hair shedding | |
| PCT/AU2015/050682 WO2016065426A1 (en) | 2014-10-29 | 2015-10-29 | Detection and treatment of excessive hair shedding |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020067194A Division JP2020109127A (ja) | 2014-10-29 | 2020-04-03 | 過剰な毛髪脱落の検出及び処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533265A JP2017533265A (ja) | 2017-11-09 |
| JP2017533265A5 true JP2017533265A5 (https=) | 2018-09-27 |
| JP6915946B2 JP6915946B2 (ja) | 2021-08-11 |
Family
ID=55856287
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017542212A Active JP6915946B2 (ja) | 2014-10-29 | 2015-10-29 | 過剰な毛髪脱落の検出及び処置 |
| JP2020067194A Pending JP2020109127A (ja) | 2014-10-29 | 2020-04-03 | 過剰な毛髪脱落の検出及び処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020067194A Pending JP2020109127A (ja) | 2014-10-29 | 2020-04-03 | 過剰な毛髪脱落の検出及び処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10226462B2 (https=) |
| EP (2) | EP3626244B1 (https=) |
| JP (2) | JP6915946B2 (https=) |
| KR (2) | KR102625061B1 (https=) |
| CN (2) | CN115998740A (https=) |
| AU (4) | AU2015337807B2 (https=) |
| CA (2) | CA3209849A1 (https=) |
| ES (2) | ES2952159T3 (https=) |
| NZ (1) | NZ732075A (https=) |
| SG (2) | SG10202002705YA (https=) |
| WO (1) | WO2016065426A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015337807B2 (en) | 2014-10-29 | 2017-05-04 | Samson Clinical Pty Ltd | Detection and treatment of excessive hair shedding |
| MX2019005833A (es) | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
| US20180189976A1 (en) | 2016-12-29 | 2018-07-05 | Michal Kasprzak | Analysis unit and system for assessment of hair condition |
| JP7191927B2 (ja) * | 2017-07-12 | 2022-12-19 | サムソン クリニカル プロプライエタリー リミテッド | 育毛促進及び脱毛または過剰な毛髪脱落の治療 |
| KR20250161056A (ko) * | 2018-09-13 | 2025-11-14 | 에이리온 테라퓨틱스, 인코포레이티드 | 플라즈미노겐 활성인자 억제제 1 (pai-1) 억제제의 용도 |
| CN109674762A (zh) * | 2019-03-05 | 2019-04-26 | 南京正大天晴制药有限公司 | 一种度他雄胺及治疗脱发的组合物胶囊 |
| CN110478450B (zh) * | 2019-10-09 | 2021-04-13 | 北海鑫臻药业有限公司 | 一种治疗阿尔茨海默病的药物组合物及其应用 |
| CN111110721A (zh) * | 2020-01-19 | 2020-05-08 | 朱炜 | 一种毛发防脱再生的复合制剂及其使用方法 |
| WO2021172060A1 (ja) * | 2020-02-27 | 2021-09-02 | パナソニックＩｐマネジメント株式会社 | 画像処理装置及び画像処理方法 |
| CA3233426A1 (en) * | 2021-09-29 | 2023-04-06 | Animesh SINHA | Hair loss therapy |
| US11744788B2 (en) * | 2021-10-27 | 2023-09-05 | James D. Welch | Method of encouraging growth and regrowth of hair in human males technical area |
| AU2023366929A1 (en) * | 2022-10-25 | 2025-05-08 | Veradermics, Incorporated | Compositions and methods of use for modified release minoxidil |
| JP2025531956A (ja) * | 2023-09-01 | 2025-09-29 | フォリア インターナショナル | 脱毛症の処置用の経口ミノキシジルに対する経口サプリメントの組成物及び方法 |
| US20250213594A1 (en) * | 2023-12-27 | 2025-07-03 | Inventage Lab Inc. | Novel long-acting injectable composition for preventing or treating androgenetic alopecia containing finasteride |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4997643A (en) | 1989-07-12 | 1991-03-05 | Union Carbide Chemicals And Plastics Company Inc. | Polymeric salt delivery systems |
| ES2070513T3 (es) * | 1990-11-14 | 1995-06-01 | Upjohn Co | Compuestos de 5-fluoro-2,4,6-pirimidintriamina para prevenir la caida del pelo. |
| US5407944A (en) * | 1993-02-19 | 1995-04-18 | Goldman; Boris E. | Compositions and methods for promoting hair growth |
| GB2314019B (en) * | 1996-06-10 | 2000-03-15 | Bio Scient Ltd | The use of L-Lysine in the treatment of hair loss |
| AU2406299A (en) | 1998-02-12 | 1999-08-30 | Centrapharm Inc. | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
| JP2000038340A (ja) | 1998-05-20 | 2000-02-08 | Kumahiro Miyama | 育毛剤および食品 |
| JP2003012542A (ja) | 2001-06-26 | 2003-01-15 | Toray Ind Inc | 発毛促進剤 |
| US20050271596A1 (en) | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
| DE102004023069A1 (de) * | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
| WO2006038315A1 (ja) | 2004-10-07 | 2006-04-13 | Kabushiki Kaisha Sangi | 経皮・経粘膜吸収製剤 |
| US20080064765A1 (en) * | 2006-09-11 | 2008-03-13 | Jacob Birnbaum | Novel hair growth compositions and methods for treating hair loss or related claims |
| WO2008067158A2 (en) * | 2006-11-13 | 2008-06-05 | Auxagen, Inc. | METHOD TO PROMOTE HAIR GROWTH AND/OR DELAY OR TREAT HAIR LOSS BY ADMINISTERING A TGF-β ANTAGONIST OR INHIBITOR |
| CA2737025C (en) | 2008-09-27 | 2012-09-04 | Jina Pharmaceuticals, Inc. | Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| US8691518B2 (en) * | 2010-09-24 | 2014-04-08 | Global Life Science Partners Limited | Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia |
| EP2510930A1 (en) | 2011-04-15 | 2012-10-17 | Bionanoplus, S.L. | Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof |
| AU2011100917B4 (en) * | 2011-07-26 | 2013-05-02 | Sinclair, Rodney Daniel Professor | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens |
| WO2013181487A2 (en) | 2012-05-31 | 2013-12-05 | Stiefel Laboratories, Inc. | Method of treating |
| AU2015337807B2 (en) | 2014-10-29 | 2017-05-04 | Samson Clinical Pty Ltd | Detection and treatment of excessive hair shedding |
| US9561224B1 (en) | 2015-05-27 | 2017-02-07 | Moshe Rogosnitzky | Methods and compositions for treating androgenetic alopecia |
| JP7191927B2 (ja) | 2017-07-12 | 2022-12-19 | サムソン クリニカル プロプライエタリー リミテッド | 育毛促進及び脱毛または過剰な毛髪脱落の治療 |
-
2015
- 2015-10-29 AU AU2015337807A patent/AU2015337807B2/en active Active
- 2015-10-29 KR KR1020177014272A patent/KR102625061B1/ko active Active
- 2015-10-29 EP EP19205898.0A patent/EP3626244B1/en active Active
- 2015-10-29 ES ES19205898T patent/ES2952159T3/es active Active
- 2015-10-29 CN CN202310057359.1A patent/CN115998740A/zh active Pending
- 2015-10-29 CN CN201580061561.5A patent/CN107106560A/zh active Pending
- 2015-10-29 KR KR1020247000993A patent/KR20240011239A/ko not_active Ceased
- 2015-10-29 SG SG10202002705YA patent/SG10202002705YA/en unknown
- 2015-10-29 CA CA3209849A patent/CA3209849A1/en active Pending
- 2015-10-29 ES ES15854489T patent/ES2773467T3/es active Active
- 2015-10-29 JP JP2017542212A patent/JP6915946B2/ja active Active
- 2015-10-29 EP EP15854489.0A patent/EP3212192B1/en active Active
- 2015-10-29 CA CA3003940A patent/CA3003940C/en active Active
- 2015-10-29 NZ NZ732075A patent/NZ732075A/en unknown
- 2015-10-29 WO PCT/AU2015/050682 patent/WO2016065426A1/en not_active Ceased
- 2015-10-29 SG SG11201703424WA patent/SG11201703424WA/en unknown
- 2015-10-29 US US15/522,599 patent/US10226462B2/en active Active
-
2017
- 2017-08-01 AU AU2017210523A patent/AU2017210523B2/en active Active
-
2018
- 2018-12-17 AU AU2018279055A patent/AU2018279055A1/en not_active Abandoned
-
2019
- 2019-01-18 US US16/252,107 patent/US11116770B2/en active Active
-
2020
- 2020-04-03 JP JP2020067194A patent/JP2020109127A/ja active Pending
- 2020-06-04 AU AU2020203695A patent/AU2020203695B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017533265A5 (https=) | ||
| FI3452039T3 (fi) | Hiustenlähtöhäiriöiden hoito deuteroiduilla JAK-estäjillä | |
| MX2024007853A (es) | Composicion farmaceutica que comprende un compuesto de quinazolina. | |
| SG11201907038WA (en) | Quinazoline compound | |
| JP2019516684A5 (https=) | ||
| WO2017083304A8 (en) | Therapeutic compositions for treatment of human immunodeficiency virus | |
| WO2017040841A1 (en) | Methods of administering elagolix | |
| JP2016540738A5 (https=) | ||
| NZ744567A (en) | Treatment of cancers using pi3 kinase isoform modulators | |
| EA202090029A1 (ru) | Твердая композиция карипразина для орального введения | |
| MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
| NZ745065A (en) | Methods for treatment and prophylaxis of hiv and aids | |
| MY163235A (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
| FI3952880T3 (fi) | 2-(2,6-dioksopiperidin-3-yyli)-4-((2-fluori-4-((3-morfolinoatsetidin-1-yyli)metyyli)bentsyyli)amino)isoindoliini-1,3-dioni käytettäväksi non-hodgkinin lymfooman hoidossa | |
| JO2792B1 (en) | Dietary supplement and method for the treatment of digestive disorders | |
| MX2023001445A (es) | Compuestos de piridazina 6-sustituidos como degradadores de smarca2 y/o smarca4. | |
| JP2013513612A5 (https=) | ||
| EA201291089A1 (ru) | Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций | |
| UA85359C2 (ru) | Таблетка, содержащая гранулированный материал с kmd-3213 | |
| JP2020527146A5 (https=) | ||
| AU2011100917B4 (en) | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens | |
| MX2018000084A (es) | Una composicion farmaceutica que comprende amlodipino, valsartan y rosuvastatina. | |
| MX2021004198A (es) | Suplemento dietetico humano y metodo para tratar trastornos del sistema digestivo y los relacionados con el sistema inmunologico. | |
| NZ751972A (en) | Treatment of prurigo nodularis | |
| WO2018158225A1 (en) | Combination of a bcl-2 inhibitor and a mdm2 inhibitor, uses and pharmaceutical compositions thereof |